Evonik Industries (XTRA:EVK) Stock Seems Overvalued After Its 61% Run

Evonik Industries has been on a strong run in 2024, and the pace of that move now puts a spotlight on whether the current share price lines up with what its earnings can support. With fresh corporate interest circling the group, the question for you is how much of its profit story is already reflected in the valuation.

• The stock is up about 60.9% year to date, which raises the stakes for anyone asking if recent earnings power can shoulder that kind of re-rating.

• Reports that BASF may increase its bid after a rejected €10.3b proposal suggest the market is trying to price in a potentially different earnings profile for Evonik Industries over time.

• The analysts covering Evonik Industries have run their own numbers. See what analysts think Evonik Industries's shares could be worth .

The issue now is whether that recent share price strength is justified by what Evonik Industries is currently earning and is expected to earn.

If you are weighing whether Evonik Industries' current price matches its earnings profile, it can help to compare that same question across 191 high quality undervalued stocks .

Has Evonik Industries Run Too Far on Earnings?

The P/E ratio suits Evonik Industries because investors are focused on what buyers might be willing to pay for each euro of current earnings. At about 82.5x earnings, the stock trades well above both the Chemicals sector average of roughly 19.0x and the peer group near 47.7x. This means the market is pricing each euro of profit at a much richer level than is typical for the industry.

The tailored fair multiple that blends Evonik Industries' growth profile, margins, size and risk points to a much lower P/E, and the model flags today's valuation as overvalued rather than close to that reference point. Because that gap is very large, the figure looks less like a precise target and more like a warning that this framework reads the shares as extremely expensive on current earnings. Despite reports that BASF may sweeten its rejected €10.3b proposal, the current P/E already embeds a heavy premium to the sector and to peers. As a result, you would need strong conviction about the earnings outlook to be comfortable paying it. Explore the numbers behind Evonik Industries's P/E valuation .

The Evonik Industries Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Evonik Industries pick up where the valuation puzzle leaves off and outline the earnings, margin and growth paths that would need to occur for the shares to be worth significantly more or significantly less than today's price. Where a ratio or model gives a single outcome, Narratives describe the future business conditions that outcome relies on so you can later judge whether those assumptions still hold on the Community page.